Is CVS Health Outperforming the Nasdaq?

finance.yahoo.com · 2026-09-04

CVS Health has outperformed the broader market over the past year, while analysts remain highly bullish on its future prospects.

TickrTrends take: CVS Health's performance relative to the broader market provides important context for assessing whether its current market price reflects its underlying fundamentals. Given TickrTrends' overvalued designation, investors focused on valuation metrics should monitor whether any outperformance against the Nasdaq is being driven by improving operational efficiency and earnings growth, or if it primarily reflects market momentum that may not be justified by the company's healthcare sector fundamentals. The gap between CVS's stock performance and its valuation assessment suggests tracking the company's ability to generate returns that would eventually justify its current trading levels.

Read the full story at finance.yahoo.com →